176 related articles for article (PubMed ID: 37901832)
1. Interaction between intratumoral microbiota and tumor mediates the response of neoadjuvant therapy for rectal cancer.
Sun L; Qu J; Ke X; Zhang Y; Xu H; Lv N; Leng J; Zhang Y; Guan A; Feng Y; Sun Y
Front Microbiol; 2023; 14():1229888. PubMed ID: 37901832
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.
Guan B; Huang X; Xia H; Guan G; Xu B
Front Oncol; 2022; 12():941786. PubMed ID: 36263216
[TBL] [Abstract][Full Text] [Related]
3. [Predictive value of combination of MRI tumor regression grade and apparent diffusion coefficient for pathological complete remission after neoadjuvant treatment of locally advanced rectal cancer].
Xu N; Huang FC; Li WL; Luan X; Jiang YM; He B
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):359-365. PubMed ID: 33878826
[No Abstract] [Full Text] [Related]
4. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral HLA-DR
Hasnis E; Dahan A; Khoury W; Duek D; Fisher Y; Beny A; Shaked Y; Chowers Y; Half EE
Front Oncol; 2020; 10():1375. PubMed ID: 32903466
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
7. Vimentin and tumor-stroma ratio for neoadjuvant chemoradiotherapy response prediction in locally advanced rectal cancer.
Tian W; Yang Y; Qin Q; Zhang L; Wang Z; Su L; Zeng L; Chen H; Hu L; Hong J; Huang Y; Zhang Q; Zhao H
Cancer Sci; 2023 Feb; 114(2):619-629. PubMed ID: 36221784
[TBL] [Abstract][Full Text] [Related]
8. FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients.
Xu K; Yin X; Zhou B; Zheng X; Wang H; Chen J; Cai X; Gao H; Xu X; Wang L; Shen L; Guo T; Zheng S; Li B; Shao Y; Wang J
Cancer Lett; 2023 May; 562():216145. PubMed ID: 36997107
[TBL] [Abstract][Full Text] [Related]
9. MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Yi X; Pei Q; Zhang Y; Zhu H; Wang Z; Chen C; Li Q; Long X; Tan F; Zhou Z; Liu W; Li C; Zhou Y; Song X; Li Y; Liao W; Li X; Sun L; Pei H; Zee C; Chen BT
Front Oncol; 2019; 9():552. PubMed ID: 31293979
[No Abstract] [Full Text] [Related]
10. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.
Teng H; Wang Y; Sui X; Fan J; Li S; Lei X; Shi C; Sun W; Song M; Wang H; Dong D; Geng J; Zhang Y; Zhu X; Cai Y; Li Y; Li B; Min Q; Wang W; Zhan Q
Cancer Cell; 2023 Jan; 41(1):124-138.e6. PubMed ID: 36563680
[TBL] [Abstract][Full Text] [Related]
11. Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.
Wang J; Liu J; Wang J; Wang S; Li F; Li R; Liu P; Li M; Wang C
Cancer Cell Int; 2022 Mar; 22(1):117. PubMed ID: 35292026
[TBL] [Abstract][Full Text] [Related]
12. Response prediction of neoadjuvant chemoradiation therapy in locally advanced rectal cancer using CT-based fractal dimension analysis.
Tochigi T; Kamran SC; Parakh A; Noda Y; Ganeshan B; Blaszkowsky LS; Ryan DP; Allen JN; Berger DL; Wo JY; Hong TS; Kambadakone A
Eur Radiol; 2022 Apr; 32(4):2426-2436. PubMed ID: 34643781
[TBL] [Abstract][Full Text] [Related]
13. The reduction of
Wu F; Zhang X; Yang C; Wang K; Xiao L; Zhou C; Zhao X; Wang G
Front Oncol; 2022; 12():1037783. PubMed ID: 36620536
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
Huang X; Chen C; Xie W; Zhou C; Tian X; Zhang Z; Wang Q; Chang H; Xiao W; Zhang R; Gao Y
Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1255-1269. PubMed ID: 37433373
[TBL] [Abstract][Full Text] [Related]
15. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
[TBL] [Abstract][Full Text] [Related]
16. Extracellular volume fraction determined by equilibrium contrast-enhanced CT for the prediction of the pathological complete response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Luo Y; Liu L; Liu D; Shen H; Wang X; Fan C; Zeng Z; Zhang J; Tan Y; Zhang X; Wu J; Zhang J
Eur Radiol; 2023 Jun; 33(6):4042-4051. PubMed ID: 36462046
[TBL] [Abstract][Full Text] [Related]
17. Identification of Blood-Based Biomarkers for the Prediction of the Response to Neoadjuvant Chemoradiation in Rectal Cancer.
Dayde D; Gunther J; Hirayama Y; Weksberg DC; Boutin A; Parhy G; Aguilar-Bonavides C; Wang H; Katayama H; Abe Y; Do KA; Hara K; Kinoshita T; Komori K; Shimizu Y; Tajika M; Niwa Y; Wang YA; DePinho R; Hanash S; Krishnan S; Taguchi A
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298853
[TBL] [Abstract][Full Text] [Related]
18. A Meta-analysis of Total Neoadjuvant Therapies Combining Chemoradiotherapy with Induction or Consolidated Chemotherapy for Locally Advanced Rectal Cancer.
Nov P; Du K; Huang Z; Li Y; Gong M; Liu X; Li C; Li L; Wang D; Zhang Y; Wang C; Li J
J Gastrointest Cancer; 2023 Sep; 54(3):693-702. PubMed ID: 36243897
[TBL] [Abstract][Full Text] [Related]
19. Adding Consolidation Capecitabine to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Propensity-Matched Comparative Study.
Fang Y; Sheng C; Ding F; Zhao W; Guan G; Liu X
Front Surg; 2021; 8():770767. PubMed ID: 35155545
[TBL] [Abstract][Full Text] [Related]
20. Developing a prediction model based on MRI for pathological complete response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Wan L; Zhang C; Zhao Q; Meng Y; Zou S; Yang Y; Liu Y; Jiang J; Ye F; Ouyang H; Zhao X; Zhang H
Abdom Radiol (NY); 2019 Sep; 44(9):2978-2987. PubMed ID: 31327039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
